Medical condition
Myasthenia Gravis
Myasthenia Gravis is a medical condition tracked by NovaPharmaNews across 7 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- azathioprine (APO-AZATHIOPRINE) Antineoplastic and immunomodulating agents (L04)
- eculizumab (SOLIRIS) Antineoplastic and immunomodulating agents (L04)
- efgartigimod alfa (VYVGART) Antineoplastic and immunomodulating agents (L04)
- zilucoplan (ZILBRYSQ) Antineoplastic and immunomodulating agents (L04)
- nipocalimab (IMAAVY) Antineoplastic and immunomodulating agents (L04)
- ravulizumab (ULTOMIRIS) Antineoplastic and immunomodulating agents (L04)
- rozanolixizumab (RYSTIGGO) Antineoplastic and immunomodulating agents (L04)
